Document is current
Any future updates will be listed below
-
Authors
Christensen, Nikolaj R
De Luca, Marta
Lever, Michael B
Richner, Mette
Hansen, Astrid B
Noes‐Holt, Gith
Jensen, Kathrine L
Rathje, Mette
Jensen, Dennis Bo
Erlendsson, Simon
Bartling, Christian RO
Ammendrup‐Johnsen, Ina
Pedersen, Sofie E
Schönauer, Michèle
Nissen, Klaus B
Midtgaard, Søren R https://orcid.org/0000-0001-6694-0626
Teilum, Kaare
Arleth, Lise
Sørensen, Andreas T
Bach, Anders
Strømgaard, Kristian
Meehan, Claire F
Vægter, Christian B
Gether, Ulrik
Madsen, Kenneth L https://orcid.org/0000-0001-9274-6691
-
Funding
Funding for this research was provided by:
Danish Council for Independent Research, Technology and Production Sciences
Danish Council for Independent Research, Medical Sciences
Sundhed og Sygdom, Det Frie Forskningsråd
Teknologi og Produktion, Det Frie Forskningsråd
Lundbeck Foundation
NOVO Nordisk Foundation
- License Information
-
More Information
Article History
Received: 5 August 2019
Revised: 1 April 2020
Accepted: 7 April 2020
First Online: 30 April 2020
Conflict of interest
: A priority founding patent application (P4997EP00; inhibitors of PICK1 and uses thereof) for Tat‐P 4 ‐(C5) 2 has been filed (KLM, UG, KST, AB, NRC).
